Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question

Staff  |  Issue: July 2009  |  July 1, 2009

A 46-year-old male with osteoarthritis of his right knee comes in for a routine follow-up office visit. The patient had an intraarticular corticosteroid injection in his right knee six weeks ago with reported improvement in knee pain and stiffness. The patient reports stiffness in the knee lasting five to 10 minutes after long car rides and in the morning, one to two times per week, and reports mild knee pain when climbing stairs. The patient also reports that his mood has greatly improved since the decrease in his knee pain, and he has no other complaints or comorbidities. He is currently taking etodoloc and ranitidine, as needed.

On examination, the patient has normal vital signs. His height is 5’10”, he weighs 190 pounds, his body mass index is 27.3, and his lungs are clear. His heart has a regular rate and rhythm, with no murmurs or friction rubs. The patient’s abdomen is soft and nontender, with no mass or hepatosplenomegaly. His right knee has crepitus and mild tenderness on extreme flexion, but no warmth or effusion. His left knee is unremarkable, with full range of motion and no tenderness.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Diagnosis: Osteoarthritis right knee; clinically stable.

Plan: The patient is given prescriptions to continue etodolac and ranitidine. He is counseled regarding the benefits of daily exercise and weight loss in the management of osteoarthritis. Ways to incorporate daily physical activity into the patient’s schedule are discussed, along with recommendations to reduce fat and caloric intake. The patient is asked to return in four months for a follow-up appointment, sooner if problems arise.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

How should this encounter be coded?

Click Here For the Answer.

Share: 

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingOsteoarthritis

Related Articles

    Exercise Therapy Recommended to Manage Knee Osteoarthritis

    July 12, 2016

    The benefits of exercise therapy for individuals with knee osteoarthritis (OA) are well known. The ACR strongly recommends both aquatic exercise and land-based aerobic and resistance exercise for managing knee OA.1 A recent Cochrane systematic review and meta-analysis concluded that high-quality evidence supports the use of exercise to reduce pain and improve physical function and…

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    Baricitinib Studied as Possible COVID-19 Treatment; Plus Ranitidine Removed from U.S. Market

    May 11, 2020

    Baricitinib, an oral JAK1/JAK2 inhibitor approved to treat RA in adults, is being investigated as a possible treatment for hospitalized patients with COVID-19…

    Changing Our Thinking on Osteoarthritis

    March 1, 2010

    It’s time we changed our thinking on osteoarthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences